APA (7th ed.) Citation

Denkinger, C. M., Janssen, M., Pohle, T., & Ruhe, M. (2023). Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: A randomized clinical trial. Nature Cancer. https://doi.org/10.1038/s43018-022-00503-w

Chicago Style (17th ed.) Citation

Denkinger, Claudia M., Maike Janssen, Thorsten Pohle, and Matthias Ruhe. "Anti-SARS-CoV-2 Antibody-containing Plasma Improves Outcome in Patients with Hematologic or Solid Cancer and Severe COVID-19: A Randomized Clinical Trial." Nature Cancer 2023. https://doi.org/10.1038/s43018-022-00503-w.

MLA (8th ed.) Citation

Denkinger, Claudia M., et al. "Anti-SARS-CoV-2 Antibody-containing Plasma Improves Outcome in Patients with Hematologic or Solid Cancer and Severe COVID-19: A Randomized Clinical Trial." Nature Cancer, 2023, https://doi.org/10.1038/s43018-022-00503-w.